Madison's Dianomi Therapeutics receives $3M investment to grow disease-treating technology
February 05, 2019 at 12:05 PM EST
In addition to capital, Ligand is providing technical and scientific advisory assistance to Dianomi for one year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.